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Introduction
Head and Neck cancer is the 7th most common cancer worldwide.  For oral 
cancer alone, in the year 2000, 266.672 new cases occurred worldwide (1). 
Oral cancer represents approximately 2 percent of all new cancer cases 
worldwide (2). Oral cancer occurs more often in men than in women. The 
worldwide male female ratio nowadays is approximately 1.5:1 (3). More 
than 90% of oral cancers consist of squamous cell carcinoma.
In the majority of patients, oral cancer occurs in the 5th through 8th decade 
of life. The mean age of the patients in a survey of the US population 
in the period 2000-2004 was 62 years (4). In the literature there are 
indications of an increasing number of patients below 40 years of age. 
This increase started in the mid seventies, persisted until the late eighties 
and then remained stable (5, 6). 
The most important etiological factors are tobacco and alcohol use. Human 
papillomavirus (HPV), particularly type 16, seems to play a role in a small 
subset of patients with oral cancer (7).
Oral cancer can present itself as an indurated ulcer or as a red, white 
or combined patch; some tumors show exophytic or verrucous growth 
(1). Tumors may arise in any part of the oral cavity, but the tongue 
and the floor of mouth are the most common sites (6,8). In an actually 
unknown percentage of cases, oral cancer is preceded for months or even 
years by clinically visible precursor lesions, in particular leukoplakia and 
erythroplakia.
Treatment of small (T1 or T2) oral squamous cell carcinoma consists in 
general of surgery, if necessary combined with radiotherapy in case of 
lymph node metastasis, extranodal spread or incomplete resection of the 
primary. In advanced tumors (T3,T4), apart from surgery, chemoradiation 
may be the treatment of choice.
In Europe, the oral cancer mortality rate has been declining over the last 
decade; a few countries i.e. Poland, Bulgaria, Belarus and Romenia still 
have increasing mortality rates in men (9). The survival rate decreases 
in patients with lymph node metastases and distant metastases. The 
overall survival rate for all stages together (regardless of different sizes 
and absence or presence of lymph node and distant metastases) is 
approximately 50%-55%, the survival rate for stage I and II is 70-85%. 
The worldwide estimated number of patients who died from oral cancer 
was 127.000 in 2008 (2).
Aim of study
The present study is mainly focussed on the clinical relevance of a number 
of histopathological aspects of small (T1, T2) squamous cell carcinomas 
(SCC) of the tongue and floor of mouth. In addition, some epidemiological 
aspects have been studied. 
In chapter 3 the clinical relevance of epithelial dysplasia in the surgical 
margins of tongue and floor of mouth squamous cell carcinoma is 
described; in chapter 4 the status of the deep surgical margins in tongue 
and floor of mouth carcinoma is studied in relation to local recurrence. All 
patients registered in the registration system of the VU University Medical 
Center (formerly known as Free University Medical Center) between 1985 
and 1995 were included in these studies.
In chapter 5 two different histopathological grading systems are compared 
in relation to a number of clinical parameters and outcome. The classical 
Broders’ grading has been compared with the more recently advocated 
malignancy grading system. This study was performed in 128 patients 
with previously untreated T1 and T2 SCC of the tongue and floor of the 
mouth.
 In chapter 6 possible differences in survival between patients with oral 
cancer developing from pre-excisting oral leukoplakia and patients with 
de novo oral cancer have been studied.
Chapter 7 is dealing with oral cancer in The Netherlands. Two groups of 
oral cancer patients from different periods of time (1980-1984 versus 
2000-2004) are compared with regard to male-female ratio, age of the 
patients, site, TNM-stage and smoking and alcohol use.
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Etiology
The most important etiological factors are tobacco and alcohol. Especially 
when combined, the risk of oral cancer increases significantly (1,2). There 
is a strong dose response relationship, and both alcohol and tobacco 
can induce oral cancer by itself. However, most cases result from the 
combined effect of smoking and drinking. The exact mechanism of the 
carcinogenic effect of alcohol remains unclear. It has been suggested 
that alcohol causes a greater permeability of the mucosa which thereby 
facilitates the penetration of carcinogenic agents from tobacco products. 
Alcohol is considered to affect also the intracellular transport mechanisms 
but further studies are necessary to investigate the exact pathways (3,4).
Since the 1980’s there is a decrease in the number of smokers. The 
incidence rates of head and neck squamous cell carcinoma has roughly 
paralleled trends in smoking. However, incidence rates of oral and 
oropharyngeal cancer are increasing (5). This pleads for the presence of 
other etiologic factors, such as human papillomavirus (HPV) infection. The 
last decade a lot of research was done, indeed, in the field of HPV related 
cancers. It was already known that HPV plays a role in the occurrence of 
cervical cancer. At present, HPV exposure and infection have particularly 
been associated with the risk of oropharyngeal cancers.
The HPV virus, especially the HPV type-16, leads to E6 and E7 activity. 
Expression of these oncogenes leads to inactivation of p53 and RB, 
leading to serious disturbances of the cell cycle regulation (6,7). Current 
opinion is that head and neck squamous cell carcinomas (HNSCCs) have 
different molecular subgroups, being HPV-positive and HPV-negative 
tumors. Tumor HPV status is considered to be an independent prognostic 
factor. HPV positive tumors are associated with better survival and lower 
risk of local recurrences and second primary tumors (8). HPV- negative 
tumors are more frequently associated with smoking and alcohol. For oral 
cancers, the influence of HPV infection is still under debate, although a 
recent meta-analysis showed a strong association between the presence 
of HPV DNA and oral squamous cell carcinoma, especially for HPV16 (9). 
The possible role of dental prosthesis in alveolar ridge carcinoma has 
been studied in the past. Denture use was not an independent risk factor 
for OSCC (10). Another etiological factor which plays an important role in 
South Asia is betel nut chewing. Because of this different etiological factor, 
the site distribution (buccal cancer being the most commonly affected 
subsite) and male-female ratio is rather different from those in Western 
Countries (11,12).
Other etiological factors that are mentioned in the literature - but without 
consensus about their role - are immunosuppressive therapy, poor oral 
hygiene, and protective role of diet (frequent consumption of vegetables 
and fruit). 
Diagnosis
Because the prognosis of the patient decreases with increasing tumor 
stage it is of great importance to detect the tumor as early as possible. 
This early detection is compromised by multiple factors varying from 
tumor behaviour to patients’ and doctors’ delay.  
Several authors have studied the effect of screening programs. Although 
the mouth is easy to access and to examine, regular screening programs 
for oral cancer are complicated by several factors. There is no consensus 
concerning the screening interval. Another factor is the cost-effectiveness 
of regular screening programs. In developed countries oral cancer is not 
a common disease. However, it might be beneficial to screen high risk 
patients (patients who abuse alcohol and tobacco) although these patients 
are often subject to non-compliance (13,14).
Instead of regular screening it might be more effective to concentrate on 
prevention like cessation of alcohol and tobacco habits (14). Alcohol as risk 
factor for oral cancer is not commonly recognized by dentists and general 
practitioners, necessitating awareness among the medical professionals 
(4). The study of Macpherson et al. (15) pleaded for continuing education 
programs for dental as well as medical care professionals including 
diagnostic skills and prevention. 
Diagnosis of OSCC is confirmed with a biopsy for histopathological 
examination. This is still the gold standard. Some clinicians use toluidine 
blue vital staining as a diagnostic aid. It may help the clinician to differentiate 
areas of epithelial dysplasia, CIS (carcinoma in situ) or invasive carcinoma 
from normal tissue. Toluidine blue is a metachromic dye, used as nuclear 
stain binding to DNA (16). Dysplastic and malignant tissues may retain 
toluidine blue due to loss of tumor suppressor genes (17). Onofre et al. 
(18) found a sensitivity of 77%  and a specificity of 67%. There were 
no false negative results in the detection of CIS and invasive carcinoma. 
However, toluidine blue is less sensitive for premalignant lesions with false 
negative rates up to 58%. In conclusion, toluidine blue can be a helpful 
tool but should not replace a biopsy. 
Chapter 2 Oral cancer; etiology, diagnosis, histopathology, staging
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Promising studies have been performed in the field of salivary biomarkers. 
In saliva of patients with an oral squamous cell carcinoma altered expression 
of proteins and mRNA markers are observed. A panel of different protein 
and mRNA markers has been studied that could discriminate between 
OSCC patients and control samples. Further studies are required to obtain 
a convenient salivary test which is easy to use, with high sensitivity and 
specificity (19).  Other clinical non invasive diagnostic aids are light based 
screening aids (ViziLite, VELscope), autofluorescence and brush biopsy. 
None of these tools are as reliable as histopathology. 
Imaging
Nowadays, Computer Tomography (CT) and Magnetic Resonance 
Imaging (MRI) are often used as additional diagnostic tools apart from 
conventional x-ray imaging like orthopantomography. The CT scan gives 
better information on the possible invasion of bone, whereas the MRI 
gives more information on the extent of the tumor and possible nodal 
involvement (WHO).
A recent review showed the importance of positron emission tomography 
(PET). PET/CT can be useful for the staging of oral squamous cell carcinoma 
as well as the follow-up of OSCC patients for its high accuracy to detect 
distant metastases and second primary cancers (20). This is particularly 
of interest for patients with an advanced stage of the disease where the 
risk of distant metastases is increased (21).
Histopathological aspects
Oral squamous cell carcinoma is a malignant epithelial neoplasm exhibiting 
squamous differentiation as characterized by the formation of keratin and 
the prescence of intercellular bridges (22). Histopathologic grading is 
widely used to indicate the tumor aggressiveness. This grading is based 
on the system of Broders (22), modified by the WHO (23). This grading 
specifically studies the degree of keratinisation, nuclear polymorphism and 
mitotic activity (grade I-III; well differentiated, moderately differentiated, 
poorly differentiated). In the last three decades modifications of this 
grading system have been developed. Most widely used is the Malignancy 
Grading System of Anneroth and Bryne (24,25). The latter advised to 
perform the grading at the tumor front because the cells at the tumor 
front are different from the cells in more superficial parts of the tumor. 
This was supported by the study of Sawair et al. (26). The mean invasive 
front grading scores were strongly associated with overall survival. 
Histopathological findings with prognostic value are state of the surgical 
margins, pattern of invasion, tumor differentiation, T-stage, perineural 
invasion, vascular invasion, positive lymph nodes and extracapsular 
spread of metastatic lymph nodes (27). 
The status of the resection margin has prognostic value. In the literature 
different definitions are given for tumor free margins. A clear margin is 
defined as “no tumor within 5 mm distance of the margin”, close margin 
as “tumor within 5 mm distance of the margin”, and positive margin as 
“tumor cells in the margin” (28,29). There is no consensus about the 
relevance of the presence of dysplasia or carcinoma in situ in the margin or 
close to the margin. However, there are strong indications that dysplasia 
in the surgical margin is a predictor of local recurrence (30,31).
Close margins may be associated with indicators of aggressive tumor 
behaviour like perineural spread and unfavourable pattern of invasion. 
Slootweg et al. (32) found a significantly higher number of distant 
metastases and local recurrence in patients with non tumor free margins. 
This was not in accordance with the findings of Brandwein-Gensler et al. 
(33). They found that margin status alone was not an independent factor 
for the prediction of local recurrence. However, in that study the presence 
of dysplasia or carcinoma in situ was not mentioned.
In recent years, a number of studies have been reported in which molecular 
markers have been used to assess the status of the surgical margins in 
relation to local recurrence (34).
Staging
Malignant tumors of the body are usually classified with the TNM-
classification. This system is also used worldwide for tumors of the oral 
cavity.  The system was developed by the Union for International Cancer 
Control (UICC). It is a widely used system to indicate tumor size (T), 
metatases to the lymph nodes in the neck (N) and distant metastases 
(M). The most recent edition of the TNM-classification and the staging 
system is depicted in table 3 (1).
ICD-codes, international classification of diseases (WHO), are the 
international standard for the registration of general epidemiological 
studies, health related studies, and clinical use. Malignant neoplasms of 
Chapter 2 Oral cancer; etiology, diagnosis, histopathology, staging
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the lip and oral cavity are separately indicated (C00-C14). Every specific 
site has its own ICD-code. For example, a malignant tumor at the border 
of the tongue is indicated as C02.1. 
World wide, approximately 50% of patients with oral and oropharyngeal 
cancers present at first admission with stages III and IV (35).
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Table I. TNM classifi cation of carcinomas of the lip and oral cavity 
T –  Primary tumor
TX  Primary tumor cannot be assessed
T0  No evidence of primary tumor
Tis  Carcinoma in situ
T1  Tumor 2 cm or less in greatest dimension
T2  Tumor more than 2 cm but not more than 4 cm in    
greatest dimension
T3  Tumor more than 4 cm in greatest dimension
T4a (lip) Tumor invades through cortical bone, inferior alveolar 
 nerve, fl oor of mouth, or skin (chin or nose)
T4a (oral cavity) Tumor invades through cortical bone, into deep/
 extrinsic muscle of tongue (genioglossus, hyoglossus,
 palatoglossus, and styloglossus), maxillary sinus, or skin of
 face
T4b  Tumor invades masticator space, pterygoid plates, or
(lip and oral cavity) skull base; or encases internal carotid artery
              Note: Superfi cial erosion alone of bone/tooth socket by
              gingival primary is not suffi cient to classify tumor as T4.
N –  Regional lymph nodes
NX  Regional lymph nodes cannot be assessed
N0  No regional lymph node metastasis
N1  Metastasis in a single ipsilateral lymph node, 3 cm or 
 less in greatest dimension
N2  Metastasis as specifi ed in N2a, 2b, 2c below
N2a  Metastasis in a single ipsilateral lymph node, more
 than 3 cm but not more than 6 cm in greatest
 dimension
N2b  Metastasis in multiple ipsilateral lymph nodes, none
 more than 6 cm in greatest dimension
N2c  Metastasis in bilateral or contralateral lymph nodes,
 none more than 6 cm in greatest dimension
N3  Metastasis in a lymph node more than 6 cm in greatest
 dimension
              Note: Midline nodes are considered ipsilateral nodes.
M –  Distant metastasis
MX  Distant metastasis cannot be assessed
M0  No distant metastasis
M1  Distant metastasis
Stage 0  Tis N0 M0
Stage I  T1 N0 M0
Stage II  T2 N0 M0
Stage III  T1, T2 N1 M0
 T3 N0, N1 M0
Stage IVA  T1, T2, T3 N2 M0
 T4a N0, N1, N2 M0
Stage IVB  Any T N3 M0, T4b, Any N M0
Stage IVC  Any T, Any N M1
Ref: L.H. Sobin, M. Gospodarowicz, Ch. Wittekind (eds). TNM Classifi cation of Malignant Tumours. 
7th ed. New York: Wiley 2009.
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Abstract
Background: The clinical relevance of the presence of epithelial dysplasia 
in the margins of surgically removed oral squamous cell carcinoma is still 
unclear.
Method: In a retrospective study, the presence of mild or moderate 
epithelial dysplasia in the surgical margins of tongue and floor of mouth 
squamous cell carcinoma was examined histologically. Patients with 
tumor cells within 0.5cm of the surgical margins were excluded. Also 
patients with severe dysplasia were excluded, as this is usually regarded 
as carcinoma in situ. Patients that received postoperative irradiation were 
also excluded. Only patients who completed a follow-up period of five 
years were included. All together, a total number of 37 patients fulfilled 
the inclusion criteria.
Results: Epithelial dysplasia was observed in 7 out of 37 patients. Five 
of these patients, and two of the 30 patients with no dysplasia, had local 
recurrence (p <0.01).
Conclusion: The presence of mild or moderate epithelial dysplasia in the 
margins of surgically removed oral squamous cell carcinoma carries a 
significant risk for the development of local recurrence. However, it should 
be noted that this study was of a retrospective nature and that the group 
of patients with epithelial dysplasia in the surgical margins was rather 
small. On the other hand, the inclusion criteria were somewhat strict, by 
limiting the oral subsite to tongue/floor of mouth, by excluding patients 
in whom tumor cells were found within 0.5cm of the surgical margins and 
by excluding patients who received postoperative radiotherapy, amongst 
others. 
Introduction
The status of the surgical margins is an important prognostic factor in oral 
squamous cell carcinomas. A positive surgical margin not only results in 
a high risk of local recurrence (1-4), but also has a negative effect on the 
survival (3). The clinical relevance of the presence of epithelial dysplasia in 
the margins of a surgically removed oral squamous cell carcinoma is less 
clear. In general, epithelial dysplasia is considered to carry an increased 
risk of future malignant transformation.
The purpose of the present study was to investigate retrospectively the 
clinical relevance of epithelial dysplasia in the margins of surgically treated 
primary tongue and floor of mouth squamous cell carcinoma with regard 
to the development of local recurrence, observing a minimum follow-up 
period of five years.
Patients and Methods
Patients
The patients included in this study were drawn from the oncology data 
base of the Department of Oral and Maxillofacial Surgery/Oral Pathology 
and the Department of Otorhinolaryngology of the University Hospital 
Vrije Universiteit Amsterdam between January 1, 1985 and January 1, 
1995.
Only patients diagnosed with a primary squamous cell carcinoma of the 
mobile tongue or floor of mouth (ICD-codes: C02.0, C02.1, C02.2, C04) 
were included, resulting in a total number of 176 patients. The TNM-
classification of the UICC was used for staging of the tumors (5).
All patients underwent surgical treatment, with or without neck dissection. 
In general, a margin of 1 cm of mucosa with a clinically normal appearance 
was observed in the removal of the primary tumor. Thirty-one patients 
were excluded from the study because of immediate postoperative 
radiotherapy, re-excision of the primary tumor due to severe dysplasia/
carcinoma in situ or frank squamous cell carcinoma in the surgical margins, 
or insufficient histopathological material. As a result, 145 patients were 
included.
Histological material
After fixation, three to four mucosal margins, through the depth of the 
surgical specimen, were generally taken, with a width of approximately 
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0.2cm. Thereafter, one or more sections were taken through the central 
part of the tumor to facilitate evaluation of the deep surgical margins. The 
number of these central sections was dependent on the size of the tumor. 
The histological slides of the surgical mucosal margins and the deep 
surgical margins were revised. All slides were stained with Hematoxylin 
and Eosin (HE). The distance between the tumor cells and the margins 
was measured with an ocular micrometer.
 
Status of the surgical margin
WHO criteria were used for the assessment of epithelial dysplasia (6). 
No attempt was made to distinguish mild from moderate dysplasia. 
Severe dysplasia was regarded as carcinoma in situ and, as a result, was 
considered tumor positive; these patients had all underwent additional 
surgery, and were excluded from this study as indicated previously.
The status of the surgical margins was divided into four categories: 
1. No tumor within 0.5 cm of the surgical margins and no epithelial 
dysplasia in the mucosal margins (47 patients)
2. No tumor within 0.5 cm of the surgical margins but presence of epithelial 
dysplasia in the mucosal margins (13 patients)
3. Tumor within 0.5 cm of the surgical margins and no epithelial dysplasia 
in the mucosal margins (63 patients)
4. Tumor within 0.5 cm of the surgical margins and presence of epithelial 
dysplasia in the mucosal margins (22 patients)
When tumor cells were observed within 0.5cm of the surgical margins, 
the patient was excluded from the study, irrespective of the presence 
or absence of epithelial dysplasia in the mucosal margins. As a result, 
categories 3 and 4 were excluded, this study being limited to patients in 
category 1 and 2, and totalling 60 patients.
Local recurrence
Local recurrence was defined as tumor development at the site of the 
primary tumor, independent of the time interval after the treatment of the 
primary.
Follow-up
In this study a follow-up period of five years was observed. Three patients 
were excluded because of non-compliance in completing the follow-
up period. Apart from the patients who had been excluded because 
of immediate postoperative radiotherapy, also patients who received 
radiotherapy in the head and neck region at a later stage during the 
follow-up period were also excluded from the study. As a result, another 
14 patients were excluded. Six  patients were also excluded because of 
death from other causes within five years. This left a total of 37 patients: 
30 patients in group 1 and 7 patients in group 2. The exclusion criteria 
have been summarised in table 1.
Table 1. Exclusion criteria in patients (n=176) treated surgically for a primary 
squamous cell carcinoma of the tongue and floor of the mouth between 1985 and 
1995 
No. of patients
●	 Immediate reexcision because of insufficient margins, 
including the presence of severe dysplasia/carcinoma in 
situ in the mucosal margins; immediate postoperative 
irradiation or irradiation during follow-up. Insufficient 
histologic material for reevaluation
           31
●	 Tumor cells within 0.5 cm of the surgical margins 85
●	 Incomplete five-year follow-up period, including death of 
other causes
9
●	 Irradiation at a later stage during follow-up 14
●	 Number of patients included in this study 37
Smoking habits
Smoking habit was available for all but one patient. For the purpose of this 
study, the patients were categorised either as a non-smoker or a smoker 
at the time of surgery, without an attempt to subdivide the latter group 
in mild, moderate or heavy smokers. There were 29 smokers, 7 non-
smokers and one patient where smoking habit was unknown. No reliable 
data could be found regarding the possible cessation of smoking habits, if 
applicable, after the surgical treatment of the primary tumor. No reliable 
data were available about alcohol consumption either.
Statistical methods
The Fisher exact test was used to examine the significance of the presence 
or absence of epithelial dysplasia in the surgical margins with regard to 
the development of local recurrence.
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Results
Local recurrence occurred in 2 out of 30 patients from group 1 and in 5 
out of 7 patients from group 2, the difference being statistically significant 
(p<0.01) (Table 2). Recurrences occurred from 9 months to 44 months 
after surgery of the primary. There was no statistically significant difference 
between smokers and non-smokers with regard to the development of 
local recurrence (Table 3).
Table 2. Local recurrence in dysplastic and nondysplastic surgical margins*
No local 
recurrence
Local 
recurrence Total
No dysplasia (group 1) 28 2 30
Dysplasia (group 2) 2 5 7
All patients 30 7 37
* p<0.01
Table 3. Local recurrence in smokers and nonsmokers (Groups 1 and 2; n=37)
Smokers Non-smokers Unknown All patients
Local recurrence 6 1 - 7
No local recurrence 23 6 1 30
All patients 29 7 1 37
p=0.7 (n.s.)
Discussion
Primary squamous cell carcinoma of the tongue or floor of mouth was 
focused on in the present study because these subsites are the most 
common ones in oral cancer. Furthermore, the surgical approach to 
carcinomas in these subsites is more or less similar.
Patients who received direct or “delayed” postoperative radiotherapy, 
particularly because of nodal disease in the neck, were excluded since the 
primary site is usually included in the field of irradiation.
There are no uniformly accepted criteria for the assessment of tumor free 
margins in surgically excised squamous cell carcinoma of the oral mucosa. 
A distance of 0.5 cm between the tumor cells and the surgical margin, as 
being defined in this study, seems an acceptable one and has  been used 
by others (3, 4, 7). Nevertheless, the distance used may also depend on 
growth pattern: in a tumor growing in a more or less solid fashion, the 
reliability of a tumor free margin of 0.5 cm is probably higher than in a 
tumor in which the tumor grows in small nests and cell groups.
Of course, the representativeness of the sections studied is a problem, 
with regard to assessment of the radical nature of the tumor and the 
assessment of the presence or absence of epithelial dysplasia in the 
mucosal margins. Therefore, some of the local recurrences observed 
in the present study may have been due to insufficiently wide surgical 
margins and not to the presence of epithelial dysplasia in the mucosal 
margins. At the same time, local recurrences in patients in the absence of 
epithelial dysplasia in the mucosal margins may perhaps be explained by 
the presence of epithelial dysplasia that was not included in the histological 
sections studied. Furthermore, there is some degree of subjectiviness 
in the assessment and grading of epithelial dysplasia, which may have 
influenced the composition of the present study groups.
Based on a small group of patients, studied retrospectively, the pattern 
of p53 immunoexpression in the surgical margins of oral squamous cell 
carcinoma  seems to be of predictive value for the future development of 
local recurrence (8).
This may justify routine examination of all patients with no epithelial 
dysplasia in the mucosal margins, as assessed by light microscopic 
examination. In another study of 25 head-and-neck cancer patients with 
negative histopathological margins, p53 mutation was observed in 13 
of them, and 5 had a local recurrence, while no such event occurred 
in the remaining 12 (9). A somewhat similar experience was observed 
in a group of 18 patients with oral squamous cell carcinoma (10). Field 
cancerization, in the explanation of local recurrence in the prescence of 
histologically negative margins, has received much attention. A recent 
paper showed that field cancerization was due to multiple independent 
events rather than migration of genetically altered cells (11).
In the present study there was no significant difference in the presence 
or absence of epithelial dysplasia in men compared to women (Table 4). 
Furthermore, no significant difference was found between the presence 
or absence of epithelial dysplasia in the tongue compared to the floor of 
the mouth (Table 5). Also there was no real correlation with T-stage and 
presence or absence of epithelial dysplasia in the mucosal margins (Table 
6).
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The finding that local recurrences are significantly more common in 
the presence of dysplasia in the mucosal margins is more or less in 
consistent with what is known about the risk of malignant transformation 
of oral leukoplakia. There, too, the risk of malignant transformation is 
significantly higher in the presence of epithelial dysplasia in comparison 
with leukoplakias in which no dysplasia is found at histological examination. 
Although occasionally a squamous cell carcinoma will develop in non-
dysplastic oral leukoplakia. It is also well known that epithelial dysplasia 
in oral leukoplakia does not always result in malignant transformation, 
although the length of the follow-up period should be taken into account 
when considering such instances. Interestingly, it has recently been shown 
that the nuclear DNA content in dysplastic cells is of stronger predictive 
value, with regard to malignant transformation in oral leukoplakia, than 
the degree of dysplasia (12).
Local recurrence has been defined  as development of tumor at the 
site of the previously removed squamous cell carcinoma in this study, 
independent of the time interval. One could perhaps defend the hypothesis 
that a time interval of less than two years would concur with the concept 
of a local recurrence, while tumor growth at the site of the previously 
removed squamous cell carcinoma over a longer time interval, could be 
regarded as a second primary. However, such distinction seems to be of 
academic interest only.
Tobacco habits do not seem to play a significant role in local recurrence 
(Table 6), although the small number of patients with epithelial dysplasia 
(n=7) does not allow statistical comparison of the possible role of 
smoking habits in patients with and without epithelial dysplasia and local 
recurrence.
In conclusion, in the absence of epithelial dysplasia in the mucosal surgical 
margins and in the absence of tumor cells within 0.5cm of the other surgical 
margins, local recurrence after treatment of a primary squamous cell 
carcinoma of the tongue or the floor of the mouth occurs in less than 7% 
during the follow-up period of five years. However, when mild or moderate 
epithelial dysplasia is present in the mucosal margins, the chance of local 
recurrence within five years after surgical removal of the primary may 
well be over 50%. Immediate reexcision, if feasible, should therefore be 
considered. The present study did not include patients in whom severe 
dysplasia/carcinoma in situ was found in the surgical margins, as those 
patients were all treated by immediate reexcision.
Table 4. Male - female distribution and presence of epithelial dysplasia
No dysplasia Dysplasia Total
Male (mean age 61.4 yrs) 14 5 19
Female (mean age 61.7 yrs) 16 2 18
Total 30 7 37
Table 5: Site distribution and presence of epithelial dysplasia
No dysplasia Dysplasia Total
Tongue 14 5 19
Floor of mouth 16 2 18
Total 30 7 37
Table 6: T-stage and presence of epithelial dysplasia
No dysplasia Dysplasia Total
T1 7 5 12
T2 13 2 15
T3 9 - 9
T4 1 - 1
Total 30 7 37
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Abstract
The objective of this study is to retrospectively assess the clinical 
relevance i.c., the event of a local recurrence, in patients surgically 
treated for tongue and floor of mouth squamous cell carcinoma when 
tumor cells are observed histopathologically at a distance of less than 
0.5 cm of the deep surgical margin. Furthermore, the pattern of invasion 
and the presense or absence of perineural spread were recorded. A total 
of 68 patients, surgically treated because of a tongue or floor of mouth 
squamous cell carcinoma, were examined. Patients in whom any degree 
of epithelial dysplasia was observed in the mucosal margins surgical had 
been excluded beforehand.
Local recurrence occurred in 2 out of 30 patients with a free  surgical 
margin >0.5cm and in 3 out of 38 patients with a free surgical margin 
≤0.5 cm, the difference being not statistically significant. Apparently, 
the presence of tumor cells within a distance of less than 0.5 cm, but 
not into the deep surgical margin, does not necessarily seem to require 
additional treatment. The pattern of invasion and the presence or absence 
of perineural spread were not significantly related with local recurrence 
either. 
Introduction
In oral squamous cell carcinomas, surgery is one of the most important 
treatment options. 
The status of the surgical margins is an important prognostic factor. 
Positive surgical margins, with tumor cells within the margin, not only 
result in a high risk of local recurrence, (1-4) but also has a negative 
effect on the survival (3).  Because of those risks, surgical therapy aims 
at obtaining ‘free’ surgical margins. However, the precise ‘safe’ distance 
between the tumor cells and the surgical margin remains unclear. 
The purpose of the present study was to investigate, retrospectively, the 
clinical relevance of the distance of the tumor cells to the deep surgical 
margins of primary tongue and floor of mouth squamous cell carcinoma 
with regard to the development of local recurrence. The relevance of 
epithelial dysplasia in the mucosal margins has been published elsewehere 
(5).
Materials and Methods
The patients included in this study were drawn from the oncology database 
of the Department of Oral and Maxillofacial Surgery/Oral Pathology and 
the Department of Otorhinolaryngology of the University Hospital Vrije 
Universiteit University Medical Center, Amsterdam in the period 1 January 
1985 and 1 January 1995.
Only patients diagnosed with a primary squamous cell carcinoma of the 
mobile tongue or floor of mouth (ICD-codes: C02.0, C02.1, C02.2, C04) 
were included, resulting in a total number of 176 patients. For the staging 
of the tumors, the TNM-classification of the UICC was used (6).  
All patients underwent surgical treatment, with or without neck dissection. 
Sixty-six patients were excluded from the study because of various 
degrees of epithelial dysplasia in the mucosal margins; severe dysplasia 
was regarded synonymous as carcinoma. Furthermore, patients were 
excluded because of immediate radiotherapy or reexcision because of 
positive margins. As a result, 110 patients were included of whom the 
deep surgical margins were free of tumor, being defined as no tumor cells 
present in the inked margin.
All histological slides of the surgical margins were revised without being 
informed about the clinical course. In our Department of Pathology, the 
protocol for the gross sectioning of the surgical specimen prescribes a 
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fixation period of at least 24h and the inking of the entire surgical surface 
with Indian ink. The lateral margins are taken first, followed by lamellation 
of the remaining specimen. The thickness of these lateral sections is 
usually in the range of 0.2-0.3 cm. Usually more than one section is taken 
from the central part of the tumor. In the present study, the deepest slide 
was included for the measurements. The distance between the tumor cells 
and the deep surgical margins was measured with an ocular micrometer.
The status of the deep surgical margins was divided into two categories;
1. No tumor within 0.5 cm (> 0.5 cm) of the surgical margin (47 patients).
2. Tumor within 0.5 cm (≤ 0.5 cm) of the surgical margins (63 patients).
The division in absence of tumor within 0.5cm (‘clear margin’) and presence 
of tumor within 0.5cm of the margin (‘close margin’) is in accordance with 
the proposal by Bataskis et al, and Sutton et al (7,8).
The histologic pattern of tumor invasion was divided in a semiquantitative 
way into three categories: 1 pushing borders or solid infiltrating tumor cells, 
2 small groups of infiltrating tumor cells, and 3 widespread dissociation of 
tumor cells. Furthermore, the presence or absence of perineural spread 
was recorded.
Local recurrence was defined as tumor development at the site of the 
primary tumor, independent of the time interval after the treatment of the 
primary.
A follow-up period of 5 years was observed. Four patients were excluded 
because of non-compliance. Patients who received radiotherapy in the 
head and neck region during the follow-up period were excluded from 
the study. A total of 18 patients (9 in category 1 and 9 in category 2) 
were excluded for this reason. Twenty patients were excluded (5 patients 
in category 1 and 15 patients in category 2) because of death of other 
causes within five years. As a result, a total of 68 patients have been 
studied: 30 patients in category 1 and 38 patients in category 2. The data 
of these 68 patients are summarised in tables 1-3. The exclusion criteria 
have been summarised in table 4.
The Fisher exact test was used to examine the significance of the surgical 
margins >0.5 cm (category 1) and ≤ 0.5 cm (category 2) with regard to 
the development of local recurrence.
Table 1. Male -  female distribution and state of deep surgical margin (n=68)*
Patients Mean age Margin 
(>0.5cm)
Margin 
(≤ 0.5cm)
Total
Male 57.7 Y 19 24 43
Female 58.5 Y 11 14 25
Total 58.0 Y 30 38 68
*ns (p> 0.01)
Table 2. Site distribution and state of deep surgical margin (n=68)*
Site Margin (>0.5cm) Margin (≤ 0.5cm) Total
Tongue   14 17 31
Floor of mouth                   16 21 37
Total 30 38 68
*ns (p> 0.01)
Table 3. T-stage and status of deep surgical margin (n=68)*
T-stage                         Margin (>0.5cm) Margin (≤ 0.5cm) Total
T1 7 13 20
T2 13 23 36
T3  9 2 11
T4  1 - 1
Total 30 38 68
*p<0.01 for T1/T2 stages compared with T3/T4
Table 4. Exclusion criteria in patients treated surgically for a primary squamous 
cell carcinoma of the tongue and floor of the mouth (n=176) 
Exclusion criteria No. of patients
* Various degrees of epithelial dysplasia in the mucosal 
margins; Immediate reexcision or postoperative 
radiotherapy because of  positive margins  
66
* Incomplete five-year follow-up period, including death of 
other causes
24
* Irradiation at a later stage during follow-up 18
* Total number of excluded patients                                                  108
Chapter 4 Status of deep surgical margins and risk of local recurrence
3938
C
h
a
p
te
r 
4
C
h
a
p
te
r 4
Results
Local recurrence occurred in 2 out of 30 patients from category 1 and in 
3 out of 38 patients from category 2, the difference being not statistically 
significant (p>0,01) (Table 5). Recurrences occurred in a range from 2 
months to 29 months after surgery of the primary. 
The pattern of invasion of the tumor cells was more or less similar in 
groups 1 and 2 ; local recurrences were equally distributed as well 
between groups 1 and 2 (Table 6). Perineural spread was not significantly 
associated with local recurrence and was equally distributed among the 
patients of groups 1 and 2 (table 7).
Table 5. Local recurrence in patients with deep surgical margins >0.5 cm and 
margins ≤ 0.5 cm*
Free Margin                   Local recurrence No local recurrence Total
> 0.5 cm                             2 28 30
≤.05 cm                             3 35 38
Total 5 63 68
*ns (p> 0.01)
Table 6. Pattern of invasion and local recurrences (n=68)*
No. of 
patients
Local
recurrences
No local
recurrences
Pattern of invasion
(n=68)
Group 1 
(n=30) 
Group 2 
(n=38)
Group 1 
(n=30)   
Group 2 
(n=38)
Pushing borders 
or solid infiltrating 
tumor cells
9 - - 5 4
Small groups of 
infiltrating 
tumor cells
49 - 3 20 26
Wide spread 
dissocation of 
tumor cells   
10 2 - 3 5
*ns (P>0.01)
Table 7. Perineural spread and local recurrence (n=68)*
No. of 
patients
Local
recurrences
No local
recurrences
Perineural spread
(n=68)
Group 1 
(n=30)  
Group 2 
(n=38)
Group 1 
(n=30)   
Group 2 
(n=38)
 Present 9 1 - 4 4
 Absent 59 1 3 24 31
*ns (P>0.01)
Discussion
The justification to focus the present study on primary squamous cell 
carcinoma of the tongue or floor of mouth was based on the fact that 
these subsites are the most common ones in oral cancer. Furthermore, the 
surgical approach of carcinomas in these subsites is more or less similar. 
Patients with various degrees of epithelial dysplasia in the mucosal margins 
have been excluded from this study, since it would be actually impossible 
to identify the cause of recurrence being either due to progression from 
epithelial dysplasia or to incomplete removal. 
The distribution of tumor cells at a distance of less than 0.5 cm and a 
distance of more than 0.5 cm in this excluded group showed to be similar 
as in the included patients group. The same aplies to the excluded patiens 
who died within 5 years because of other causes. 
Patients who received direct or “delayed” postoperative radiotherapy, 
particularly because of nodal disease in the neck, were excluded since 
the primary site is usually included in the field of irradiation and, thus, 
may have influenced the risk of local recurrence. It is unlikely that the 
exclusion of this group of patients has caused a bias with regard to the 
distribution of the two study groups, being tumor cells at a distance of 
less than 0.5 cm and of more than 0.5 cm.
There are no uniformly accepted histopathological criteria for the 
assessment of tumor free margins in surgically excised squamous cell 
carcinoma of the oral mucosa. A distance of 0.5 cm between the tumor 
cells and the deep surgical margin, as being defined in this study, has 
also been used by others (2,3,9). Interestingly, in the present study, no 
significant difference was found between the categories with tumor cells 
at a distance of less than 0.5 cm and a distance of more than 0.5 cm from 
the deep margin with regard to the development of local recurrence. In 
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further studying group 2 (tumor at a distance of less than 0.5 cm) four 
patients were observed with tumor not truly into the margin but at a 
distance of approximately 0.1 cm; none of these patients developed a 
local recurrence during the 5-year follow-up period. Of the three patients 
of group 2 who did develop a recurrence, closeness of tumor cells to the 
deep surgical margin was 0.13 cm, 0.41 cm and 0.44 cm respectively. 
Therefore, the need for subdividing the group of patients with tumor cells 
present at a distance of less than 0.5 cm into subgroups, e.g. less than 
0.1 cm, 0.1-0.3 cm and 0.3-0.5 cm seems questionable. Local recurrences 
in our group can not be explained by the possible presence of epithelial 
dysplasia in the mucosal  resection margins since those patients had been 
excluded. 
In order to obtain tumor free margins, it is important to take the shrinkage 
of tumor tissue into account. Apparently the tumor tissue shrinks after 
resection and during the preparation of the slides. Johnson et al,  studied 
the amount of tissue shrinkage in mongrel dogs (10). They found that 
the deep tongue margin shrank almost 34.4%. Their advise to obtain 
a pathologically clear margin of 0.5 cm was to take an surgical in-situ 
margin of at least 0.8-1.0 cm, what is indeed common practice.
Our protocol of gross sectioning of the surgical specimen (taking the 
lateral margins first, followed by lammelation of the remaining specimen 
results in a rather accurate information of tumor extension in the vertical 
dimension (deep surgical margins) but less so into the horizontal dimension 
(lateral surgical margins).
Remarkably, our patients with T3/T4 tumors more often showed tumor 
free margins than patients with T1/T2 tumors (table 3). This difference 
was statistically significant. An explanation for this finding might be the 
fact that surgeons tend to excise larger tumors more aggressively than 
small ones.  
Looser et al, in their study found a great number of local recurrences 
in patients with tumor cells within 0.5 cm distance of the margin (2). 
However, their study was based on different sites within the head and 
neck region and some patients received preoperative radiotherapy. 
Hicks et al, found a much lower local control rate in patients with margins < 
0.5 cm (11). However, no distinction was made between positive margins 
and margins < 0.5 cm. This was also the case in the study of Al-Raji et 
al,  in which the recurrence free survival percentage was much higher 
in patients with margins < 0.5 cm, but in their study, too, patients with 
positive margins were included (9). A factor that might have influenced 
the outcome of the present study is the way of categorizing the patients; 
the dichotomy was somewhat arbitrarily set at 0.5 cm.
The significance of the distance between the tumor cells and the deep 
surgical margin may also be dependent on the pattern of invasion of the 
tumor and the presence or absence of perineural spread. Apparently, this 
was not the case in the present study, nor with regard to the pattern of 
invasion neither with regard to the presence of perineural spread (12).
In conclusion, the histopathological demonstration of tumor cells within a 
distance of less than 0.5 cm, but not into the deep surgical margins, does 
not necessarily seem to require additional treatment.
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Abstract
There is an ongoing debate about the predictive value of histopathological 
parameters in oral cancer. In the past decades, the emphasis has been 
on the possible added value of the so-called malignancy grading system.
In a retrospective study on 128 previously untreated patients with a T1 or 
T2 squamous cell carcinoma of the tongue and the floor of the mouth the 
value of the classical Broders’ grading system and the malignancy grading 
system were compared with regard to various outcome measures such as 
regional metastasis, local recurrence and 5-year survival.
The results show that neither histological grading system has a strong 
predictive value and that none is superior to the other.
Introduction
There are several clinical and histopathological parameters which are used 
to assess the prognosis of oral squamous cell carcinoma. The prognostic 
value of the TNM-classification system is rather limited (1-4). Therefore, 
other parameters have been investigated, particularly histopathological 
ones. The most commonly used histopathological grading system is the 
one introduced by Broders (5) and modified by the WHO (6). However, 
its prognostic value seems questionable. In the late 1980’s, a more 
detailed histopathological grading system has been introduced, referred 
to as malignancy grading system. Apart from the degree of keratinization, 
nuclear polymorphism and number of mitoses also parameters of the 
tumorhost relationship, such as pattern of invasion, stage of invasion and 
density of the tumor related lymphoplasmacytic infiltration, are included 
in this system (7-9). Several studies have shown the predictive value 
of this malignancy grading system with regard to the occurrence of late 
cervical metastases (10-13).
The purpose of the present study was to investigate the prognostic value 
of histopathological parameters in squamous cell carcinomas of the tongue 
and floor of the mouth, as expressed in 5-year survival rate and first 
event such as local recurrence, regional metastases and second primary 
tumors. The parameters that have been applied are the histological 
grade of differentiation according to Broders and the malignancy grading 
system according to Anneroth et al. (7) Furthermore, perineural and 
angiolymphatic invasion were studied. The state of the resection margins 
with regard to local recurrence has been discussed in previous reports 
(14, 15).
Patients and Methods
Patient material
A group of  consecutive patients surgically treated, with or without elective 
neck dissection, for a primary squamous cell carcinoma of the tongue or 
floor of the mouth (ICD-codes: C02.0,1,2/C04) at the Vrije Universiteit 
Medical Centrum (VUmc) in Amsterdam between January 1985 and 
January 1995 were studied. The tumor stages were limited to stage I and 
II. Patients were excluded from the study in case of previous malignancies 
in or outside the oral cavity, immediate reexcision of the primary tumor, 
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and postoperative radiotherapy. Patients were also excluded from the 
study in case of tumor cells within the resection margins and/or positive 
lymph nodes. As a result, 128 patients were included.
For the staging of the tumors, the TNM-classification of the UICC 2002 
was used (16). 
The following events were registered: local recurrence, regional 
metastases, and the development of a second primary tumor in or outside 
the head and neck region. The minimum followup period was five years. 
Local recurrence was defined as tumor development within 2 years at 
the site of  the primary tumor. A second primary was defined as tumor 
development at a different subsite than that of the primary tumor, 
irrespective of the time interval or at the site of the primary tumor at least 
2 years after removal of the primary tumor. Neck node metastases were 
defined as cytologically or histologically proven presence of squamous cell 
carcinoma in one or more lymph nodes. The demographic data and data 
on treatment are shown in table 1. 
The occurrence of first events was as follows; 29 patients (23%) had 
regional metastasis, 13 patients (10%) had a local recurrence, and 6 
patients (5%) developed a primay tumor in the oral cavity or oropharynx. 
The overall 5-year survival rate was 67%; 11% of the patients died of 
their oral cancer. Four percent were alive with evidence of disease, 7% 
died of second primary cancer and 11% died of other causes. 
Table 1. Demographic data of 128 patients (tongue 67; floor of mouth 61)
Male 82
Female 46
Male-female ratio 1.8
Mean age (yrs) 62 (range 37-87)
Stage I 63
Stage II 65
Local treatment 86
Local treatment and elective neck dissection 42
Histopathology
For the purpose of the study, re-assessment of the original slides was 
performed by an oral pathologist (IvdW). The pathologist was not aware 
of the original report of the slides or the identitiy of the patient. In our 
department of pathology, the protocol for the gross sectioning of the 
surgical specimen prescribes the taking of the lateral margins followed by 
lamellation of the remaining specimen. Usually, more than one section is 
taken from the central part of the tumor. In the present study, all sections 
were re-assessed. 
Table 2. Broders’ grade in 128 patients
Broders’ grade Number of patients
I 42
II 83
III 3
Total 128
Broders’ grading was performed on the entire tumor mass and the results 
are shown in table 2. The malignancy grading was performed at the 
forefront of the tumor according to the system of Anneroth et al. (7) The 
total malignancy score according to the system of Anneroth was divided 
into four groups: (i) score 12 and below (n=26  20%), (ii) score 13 (n=36 
28%), (iii) score 14 (n=44 34%), and (iv) score 15 and higher (n=22 
17%). The scores for each histopathological item are shown in table 3; 
the distribution of the total malignancy score is shown in figure 1. 
Perineural invasion was defined as infiltration of the perineural space 
by tumor cells. This feature was assessed within the whole tumor. This 
phenomenon was present in 13 patients (10%), absent in 114 (89%) 
and not assessable in one patient (1%). Angiolymphatic invasion was 
defined as the presence of aggregates of tumor cells within endothelial-
lined channels or invasion of the media of a vessel with ulceration of 
the overlying intima. No distinction was made between blood vessels 
and lymphatic vessels.  For this purpose Elastica von Gieson stains were 
examined. Angiolymphatic invasion was present in 12 patients (9%), 
absent in 112 patients (89%) and not assessable in 4 patients (2%).
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Table 3. Distribution of the different parameter scores of the malignancy grading 
system in 128 patients
Parameter Score Number of patients
Degree of keratinisation 1 7
2 108
3 13
4 -
Nuclear polymorphism 1 5
2 119
3 4
4 -
Number of mitosis 1 102
2 25
3 1
4 -
Pattern of invasion 1 1
2 17
3 95
4 15
Stage of invasion 1 -
2 5
3 50
4 73
Lymphoplasmacytic infi ltration 1 47
2 69
3 11
4 1
Statistical analysis
Percentages were compared with the Chi square test (except for the smaller 
groups). P < 0.05 were considered as indicating statistical signifi cance. 
Results 
Limiting the Broders’ system to grades 1 and 2, there was no signifi cant 
difference in differentiation and occurrence of the various fi rst events 
(table 4, p-values > 0.25). There was no signifi cant difference either in 
survival between the patients with well differentiated and moderately 
differentiated tumors (table 5, p-values > 0.20). Because of the small 
number of patients with grade 3, these have not been included in the 
analysis. 
Using the malignancy grading system of Anneroth, there was  no difference 
in the occurrence of the various fi rst events between the four groups (table 
6, p-values > 0.15) . There was no statistically signifi cant difference in 
survival between patients with low and high malignancy scores either 
(table 7, p-values > 0.50). None of the parameters of the malignancy 
grading system was statistically shown to have more predictive value than 
the others.
A tendency was seen that in patients with regional metastases growth 
in vessels was more common; there was also a tendency that perineural 
spread was more common in patients who died of their oral cancer. 
However, both fi ndings were not statistically signifi cant.
Figure 1 Distribution of total malignancy scores in 128 patients  
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Table 4. Broders’ grade and first event; no significant differences
Broder’s grade I II III* All grades
Disease free after 5 years 24 39 3 66
Regional metastases 10 19 - 29
Local recurrence 3 10 - 13
2nd Primary oral cavity or oropharynx 1 5 - 6
2nd Primary elsewhere 4 7 - 11
Death of other causes - 3 - 3
Total number of patients 42 83 3 128
* Not included in the analysis because of small number of patients
Table 5. Broders’ grade and patient status at five-year of follow-up; no significant 
differences
Broder’s grade I II III* All grades
Alive no evidence of disease 31 52 3 86
Alive evidence of disease - 5 - 5
Death of disease 5 9 - 14
Death of other causes 3 11 - 14
Death of 2nd primary 3 6 - 9
Total number of patients 42 83 3 128
* Not included in the statistical analysis because of small number of patients
Table 6.  Total malignancy score and first event; no significant differences
Total number of 
patients
Total malignancy score -12 13 14 15- 128
Disease free 18 18 18 12 66
Regional metastases 3 10 10 6 29
Local recurrence 2 3 7 1 13
2nd Primary oropharynx - 1 4 1 6
2nd Primary elsewhere 2 3 4 2 11
Death of other causes 1 1 1 - 3
Total number of patients 26 36 44 22 128
Table 7. Total malignancy score and patient status end of follow up; no significant 
differences
Total number of 
patients
Total malignancy score -12 13 14 15- 128
Alive no evidence of disease 19 21 30 16 86
Alive evidence of disease - 1 3 1 5
Death of disease 1 5 6 2 14
Death of other causes 3 5 4 2 14
Death of 2nd primary 3 4 1 1 9
Total number of patients 26 36 44 22 128
Discussion
The present study was deliberately restricted to patients with small 
squamous cell carcinoma of the tongue and floor of the mouth without 
lymph node metastases to assess reliably the prognostic value of 
histopathological parameters with regard to local recurrence, regional 
metastasis and 5-year survival. For the same reasons, patients who 
received post-operative radiotherapy have been excluded. To the best of 
our knowledge, no comparable selection criteria have been used in other 
papers on this subject. 
Bryne et al. compared Broders’ grading system with the malignancy 
grading system according to Anneroth and found no prognostic value for 
Broders grading, whereas the malignancy grading system according to 
Anneroth did. (8) In contrast to our study, Odell et al. found that a less 
differentiated Broders’ grade correlated with an increased risk of local 
recurrence (9). Keski-Santti et al. studied different histopathological 
parameters (mode of invasive front, pattern of invasion, histological 
grade and depth of invasion (measured in mm) (17). Their outcome was, 
like in the present study, that none of the individual parameters of the 
malignancy grading system had prognostic significance with respect to 
survival. The measured depth of infiltration and p-T stage predicted occult 
cervical metastasis; p-T stage also predicted local recurrences. It should 
be mentioned that the study by Keski-Santti et al. was limited to stages 
I and II, as in the present study, but only included carcinomas of the 
tongue.
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Woolgar et al., applying the malignancy grading system, concluded that 
the degree of keratinisation, mitotic figures and pattern of invasion did 
have a significant value in predicting metastases (18). Many investigators 
omitted the feature ‘number of mitoses’, because of interobserver 
disagreement, tumor heterogeneity and variations in the high power 
fields between different microscopes (9, 19, 20). Woolgar et al. found that 
the frequency of mitotic figures was significantly higher in patients with 
regional metastases (18). In the present study, this observation could not 
be confirmed. In 1999 Woolgar found a correlation between histological 
malignancy grade (HMG) and the occurrence of lymph node metastases 
(21). A correlation was found between HMG and survival. 
Amaral et al. studied the predictive factors of occult metastasis and 
prognosis of stage I and II carcinoma of the tongue and floor of the 
mouth (22). They found that muscular infiltration was associated with 
the presence of occult metastasis. This factor was also associated with 
disease free survival.
In a study by Kurokawa et al., using the malignancy grading system, a 
high prognostic value of the histological grade in the deep invasive front 
of tongue squamous cell carcinoma was observed (23). It is difficult to 
comment on those findings, since also patients with stage III and stage 
IV had been included. Besides, probably a number of these patients have 
received postoperative radiotherapy.
Vascular and perineural invasion were studied because of their possible 
prognostic value with regard to cervical metastasis. Poleksic et al. (24), 
Shingaki et al. (25), Brown et al. (26), Woolgar et al. (18, 21) and Yuen 
et al. (27) found a significant prognostic value for perineural invasion 
with regard to local recurrence. Woolgar et al. found in their study that 
both vascular and perineural invasion had significant independent value 
in predicting nodal metastases (18). Like in the present study, no attempt 
was made to distinguish between lymphatic and blood vessels. Fagan et al. 
also found that perineural invasion was associated with an increased risk of 
local recurrence and cervical metastases (28). In their study, Sutton et al. 
found that the presence of perineural spread and/or vascular invasion was 
strongly related to close or involved margins (29). McMahon et al. found 
that local recurrence was predicted by the presence of perineural invasion 
(30). This is not in accordance with the results of the present study. Finally, 
Amaral et al. found that the presence of vascular invasion was associated 
with occult metastasis in tongue tumors (22). As mentioned before, there 
is no similary designed study reported in the literature that would allow 
comparison with the present results. Furthermore, it is well recognized 
that stage I and II oral squamous cell carcinomas have a relatively good 
prognosis and that any grading or scoring system may be too crude to be 
of value in such select group. 
Conclusion
In the present study, no significant predictive value for Broders’ system 
and the malignancy grading system of Anneroth was found in T1N0 and 
T2N0 squamous cell carcinomas of the tongue and the floor of the mouth. 
Because P-values are high, this cannot be explained by lack of power. 
Tumor growth in vessels tend to be a risk factor for regional metastasis, 
but not at a significant level. The same applies to perineural spread with 
regard to poor survival.
At present, no biological markers are available that have shown to be of 
more prognostic value than the traditional histopathologic parameters.
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Abstract
Background: It has been suggested that patients with squamous cell 
carcinomas derived from oral leukoplakia have a better prognosis than 
patients with carcinomas that are not associated with oral leukoplakia. 
Aim: To study the mortality rate of 19 patients with a squamous cell 
carcinoma derived from pre-existing oral leukoplakia.
Method: The mortality rate of 19 patients with a proven oral squamous 
cell carcinoma derived from a pre-existing oral leukoplakia was compared 
with that of a similar size group of patients with oral carcinoma without 
a pre-existing oral leukoplakia, being matched for gender, age, smoking 
habits, use of alcohol, oral subsite and histopathologic grade. Treatment 
in all patients was primarily by surgical excision. The mortality rates up 
to 5 years have been computed according to the Kaplan-Meier method.
Result: No significant difference of the mortality rates up to 5 years of 
follow-up was observed between the two groups of patients.
Conclusion: Patients with oral cancer developing from pre-existing oral 
leukoplakia do not do better than those with de novo oral cancer. 
Introduction
It has been stated that squamous cell carcinomas associated with or 
derived from oral leukoplakia appear to be smaller, to be histologically 
more mature, to be only superficially invasive and, therefore, provide a 
better prognosis than similar carcinomas that are not associated with oral 
leukoplakia (1).
The present study was undertaken to compare the 5-year mortality rates 
of patients with an oral squamous cell carcinoma arisen from pre-existing 
oral leukoplakia with a matched control group of patients with de novo 
oral squamous cell carcinoma.
Patients and methods
Nineteen patients with an oral squamous cell carcinoma that had developed 
from pre-existing oral leukoplakia were matched with a group of 19 patients 
with a primary oral squamous cell carcinoma drawn from the oncology 
data base of the Department of Oral and Maxillofacial Surgery of the 
Vrije Universiteit University Medical Center, Amsterdam, the Netherlands. 
Matching was performed with regard to gender, age, smoking habits, use 
of alcohol, oral subsite, TNM stage and histopathologic grade.
The group of patients with pre-existing oral leukoplakia has been published 
in detail elsewhere (2). The data of both patients groups are summarized 
in Table 1. All patients of both groups were initially treated by surgery.
All but one carcinoma developed inside the region of the leukoplakia. The 
malignant transformation occurred in a mean period of 32 months (range 
6–201 months). The mortality rates up to 5 years for both groups of 
patients have been computed according to the Kaplan–Meier method (3), 
allowing for patients lost to followup.
Mortality was defined in two ways: from all causes or from oral squamous 
cell carcinoma. The patient groups were compared with the log rank test. 
The results were considered statistically significant if the value of P < 
0.05.
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Table 1 Matching data of 19 patients with a squamous cell carcinoma arisen in a 
pre-existing oral leukoplakia and 19 patients with de novo carcinoma
Carcinoma arising from
Pre-excisting oral 
leukoplakia                           
Carcinoma 
arising
de novo
Number of patients 19 19
Gender
Male 3 3
Female 16 16
Mean age (years) 71.6 71.5
Smoking habits
Non-smokers 12 12
Smokers 7 7
Alcohol use
Non-users 10 11
Users 9 8
Oral subsite
Tongue (mobile part) 9 11
Floor of mouth 3 3
Cheek 2 2
Lower jaw 2 2
Multifocal 2 1
Unknown 1 -
TNM Classification
T is 2 1
T1 7 6
T2 8 9
T3 1 3
T4 1 -
All patients were clinically 
staged as N0 M0
Histopathologic grade
Carcinoma in situ 2 1
Well-differentiated 8 11
Moderately⁄poorly 
differentiated
8 7
Verrucous carcinoma 1 -
Results
In Table 2, the follow-up of the patient groups, including the 5-year 
mortality according to the Kaplan–Meier method, have been shown for 
both definitions of mortality. No statistically significant differences between
the groups were found (log rank test; P = 0.38 and 1.00 respectively).
Table 2 Five-year follow-up data of 19 patients with a squamous cell carcinoma 
arising in a pre-existing oral leukoplakia and 19 patients with de novo carcinoma
Carcinoma arising from
Pre-excisting oral  
leukoplakia
Carcinoma
arising
de novo
Number of patients 19 19
Lost to follow-up 1a 3b
Dead of other causes 3c 6d
Dead of disease 3 3
Five-year mortality rate (%), 
all causes
32 53
Five-year mortality rate (%), 
carcinoma
16 20
a After 1 year.
b After 1 and 2 years (two patients), respectively.
c After 1, 2 and 3 years respectively.
d After 2 years (four patients), 3 years and 4 years respectively.
Log rank: p = 0.38 (all causes) and p = 1.00 (carcinoma).
Discussion
The disproportional gender ratio in the pre-existing oral leukoplakia group 
was the reason to match for gender.
The same applies for the reason to match for the oral subsite, the 
prevalence of tongue carcinomas in the preexisting oral leukoplakia group 
being rather high, e.g. in comparison with the prevalence of cancer of the 
floor of the mouth.
In patients being followed for possible malignant transformation of their 
oral leukoplakia one would expect to encounter only T1 carcinomas. 
Apparently, this has not been the case. Just over half of the patients had T2 
or even larger carcinomas. The large size of the carcinomas can probably 
be explained by the follow-up intervals of the leukoplakia patients, that 
varied from 3 to 12 months, while some of these patients were even lost 
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to follow-up until the time that they were readmitted because of cancer 
development (2). In a recent Cochrane review, it has been concluded 
that treatment of oral leukoplakia does not necessarily preclude future 
development of a squamous cell carcinoma (4). Therefore, close follow-up 
of both treated and untreated patients may be warranted, although the 
benefit of such follow-up visits has still not been proven yet. There are no 
universally accepted guidelines in the literature about the period of the 
intervals, e.g. 6 months, of such followup visits, nor about the length.
In the pre-existing leukoplakia group, a relatively large proportion of non-
smokers and non-users of alcohol was observed. This finding too can be 
explained by the source of the study group, i.e. the patients who had 
their cancer developing from a leukoplakia. It is generally accepted that 
malignant transformation of oral leukoplakia is more likely to occur in 
smokers than in non-smokers. Less is known about the possible role of 
alcohol in the prediction of malignant transformation of oral leukoplakia.
In view of the rather limited number of patients, the present data should 
be looked upon carefully. Nevertheless, the figures do no support the 
hypothesis that patients with oral carcinomas associated with or derived 
from oral leukoplakia have a better prognosis than those with an oral 
carcinomas without concomitant or preceding oral leukoplakia. Although 
mortality from all causes seems lower, this is far from significant (p = 
0.38).
In our oral leukoplakia-derived cancer patients another four patients died 
from their disease after 7,12, 18 and 19 years respectively. These long-
term follow-up data could not be compared with the findings of the de novo 
group, as the maximum follow-up period of that group lasted 10 years 
only. It has been suggested that patients with carcinoma of the tongue 
with concomitant oral leukoplakia show a five times greater incidence of 
the development of subsequent multiple carcinomas of the oral cavity and 
pharynx than patients without oral leukoplakia, which likely may result in 
a poorer prognosis (5).
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Abstract
Objectives: In this study we evaluated the possible epidemiologic changes 
of oral cancer patients in the Netherlands between the years 1980-1984 
and 2000-2004. We specifically studied the differences in male-female 
ratio, age, TNM-stage, site distribution, and alcohol and tobacco use. 
Materials and Methods: Patients from the VU University Medical Center 
with an oral squamous cell carcinoma of the oral cavity registered in 
1980-1984 (n=200) Group 1,were compared to patients registered in 
2000-2004 (n=184) Group 2. Trends in prevalence, site distribution, 
TNM-stage, alcohol and tobacco use, age and gender were studied. 
Results: The male-female ratio has decreased from 1.8 to 1.2. There 
were no differences in age between the two groups of patients. The site 
distribution was similar in both groups. The most commonly involved sites 
were the tongue and the floor of mouth. 
In  group 2 more patients were diagnosed with a T1 tumor.  There were no 
differences in tobacco use between the two different groups. There were 
much more light drinkers (0-2 drinks per day) in group 2 than in group 1, 
whereas there were more heavy drinkers (>4 per day) in group 1 than in 
group 2 (p=<0.001). This was observed in both male and female patients. 
Conclusion:  In our study there were no significant differences between 
the patients registered in the years 1980-1984 and 2000-2004 regarding 
the mean age of the patients, site distribution and smoking habits. The 
male female ratio has decreased. In the recent group more patients were 
staged T1N0 and there was a strong decrease of the patients who were 
heavy drinkers.
  
Introduction
Squamous cell carcinoma makes up approximately 90% of oral cancers, 
the remaining 10%  consisting of malignant salivary gland tumors of the 
accessory glands, melanoma, sarcomas of the soft tissues and the jaw 
bones, malignant odontogenic tumors, non-Hodgkin lymphomas and 
metastases from primary tumors located elsewhere in the body. 
The main etiologic factors of oral squamous cell carcinoma (OSCC) are 
tobacco and alcohol use (1-3). Human papilloma virus, particular type 16, 
may play an etiologic role in a small subset of patients (4).
In the past decade several studies have been published that showed an 
increase in the incidence of OSCC, a tendency to occur  more often in the 
age group below the age of 40 years.
In the present study the possible epidemiologic changes of oral cancer 
patients treated at the VU University Medical Center, Amsterdam, have 
been examined comparing the periods 1980-1984 and 2000-2004. We 
specifically studied the possible differences in the male-female ratio, age, 
subsite distribution, TNM-stage, and alcohol and tobacco use. 
Material and Methods
Patients were drawn from the oral cancer database of the VU University 
Medical Center, Amsterdam, the Netherlands. In this study only patients 
with a squamous cell carcinoma of the oral cavity were studied (ICD 10 
141, 143-145). 
The data of patients registered in the period 1980-1984 were compared 
to those of patients registered in the period 2000-2004. For the statistical 
analysis  chi-square tests were used and an independent sample t-test for 
the difference between the groups regarding age. A p value < 0,05 was 
considered as statistical significant. 
Results 
In the period 1980-1984 (group 1) a total number of 200 patients with an 
oral squamous cell carcinoma was registered, while that number was 184 
in the period 2000-2004 (group 2). 
Gender and age are summarized in table 1. The ICD codes and specified 
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sites are depicted in table  2. The clinical T and N stages are depicted in 
table 3, while the data about smoking habits and the use of alcohol are 
summarized in tables 4 and 5, respectively.  
Table 1: Demographic data
Group 1 
(1980-1984)
N=200
Group 2 
(2000-2004)
N=184
P value
Male
Female
129 (64.5%)
71 (35.5%)
102 (55.4%)
82 (44.6%)
0.070
Mean age (SD) 64 (12.97) 63 (12.65) 0.238
Number of patients 
below 40 years 10 8 0.763
Note: no statistically significant differences were observed between the two periods
Table 2: Localisation of oral squamous cell carcinomas
Localisation Group 1 (1980-1984) Group 2 (2000-2004)
Lower Lip
(C00.1, 2, 4, 5, 8, 9) 14 17
Tongue
(C02.0, 1, 2, 3, 8, 9) 57 58
Gingiva maxilla
(C03.0) 10 4
Gingiva mandible
(CO3.1) 40 26
Floor of Mouth
(C04.0, 1, 8, 9) 62 51
Cheek
(C06.0) 7 9
Palate
C05.0, 1, 9 5 2
Multifocal
C06.8 2 2
Other 3 15
Total 200 184
Note: no statistically significant differences were observed between the two periods. 
The male-female ratio in group 1 was 1.8: 1 and this ratio was 1.2: 1 in 
group 2. There were no significant differences in age between the two 
groups of patients. No increase of  patients under the age of 40 years was 
observed. The distribution of the oral subsite of the tumours as indicated 
in (table 2) showed no change either. The most common subsites were 
the lateral borders of the tongue and the floor of mouth. 
The T-stage is visualized in table 3. There are more patients in group 2 
with T1 stage (p 0.015) compared to the patients from the first group. The 
N-stage is also shown in table 3.  There are significantly more patients in 
the  group 2 with a lower N-stage, (p<0.001) than in the first group.
There were no statistically significant differences in tobacco use in both 
men and women between the two periods. With regard to the use of 
alcohol a statistical significant difference was found: there were more 
light drinkers in the category 0-2 drinks per day in group 2 than in group 
1, whereas there were more heavy drinkers (>4 per day) in group 1 than 
in group 2 (p=<0.001). This was found in both male and female patients. 
Table 3: T-stage, N-stage and T1N0
 T-stage Group 1 (1980-1985)n=200
Group 2 (2000-2004)
n=184
T1 48 69*
T2 84 60
T3 48 32
T4 20 23
N-stage
N0 124 148**
N1 55 22
N2 15 14
N3 6 -
T1N0 45 66***
 * There is a significant higher number of patients with T1 in group 2 (p=0.015)
**There is a significant increase in patients with N0-stage in group 2 (p<0.001)
***There is a significant increase in patients with T1N0-stage in group 2 (p=0.032)
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Table 4: Smoking habits
Smoking habits Group 1 (1980-1985) Group 2 (2000-2004)
 Total Men Women Total Men Women
Non-smoker 58 22 36 62 27 35
<10 sig/day 10 7 3 5 3            2
10-20 sig/day 38 33 5 22 17 5
>20 sig/day 82 61 21 67 38 29
Not registered 12 - - 28 - -
Total 188 123 65 156 85 71
Note: no statistically significant differences in smoking habits among men (p=0.120) and 
women (p=0.745) in the two periods. 
Table 5: Alcohol use
Alcohol use Group 1 (1980-1985) Group 2 (2000-2004)
 Total Men Women Total Men Women
None 44 18 26 23 9 14
0-2 per day 32 16 16 60 31            29
 2-4 per day 49 41 8 37 22 15
 >4 per day 59 45 14 27 19 8
Not registered 16 9 7 37 21 16
Total 184 120 64 147 81 66
Note: there were statistically significant more light drinkers (0-2 per day) in the second 
period, both in men (p=0.001) and women (p=0.011).
Discussion
In the majority of the literature an increase of patients with oral cancer 
was observed in the past decades. 
Warnakulsaya et al. stated that in the last two decades there was an 
increase of both oral and oropharyngeal cancer in Western Europe (5). 
Karim-Kos et al. found an increase of smoking related cancers in whole 
Europe (6). Curado et al. comparing data from 1998 and 2002 found an 
increase in incidence in oral cancer for both men and women for North and 
East Europe and a stable incidence in the West of Europe (7). However, 
it seems somewhat questionable to compare data obtained from two 
periods with an interval of just four years. 
On the other hand, a decrease in the age-standardized incidence of oral 
squamous cell carcinoma in the last three decades in the U.S. has been 
reported (8). In a recent European study it was noted that oral cancer 
mortality has started to decline in generations born after the 1950’s (9). 
Since there was no formal cancer registry in the Netherlands yet in the first 
period (1980-1984) no reliable information is available about a possible 
increase of oral cancer in the Netherlands when comparing the period 
1980-1984 and the period 2000-2004. Braakhuis et al. reported a stable 
incidence for oral cancer in men and an increasing incidence in women 
over the years 1989-2006 (10). 
The male-female ratio decreased in the present study. This is also seen in 
other studies (6). Apparently, this decrease was not related to a decrease 
of smoking habits among men nor an increase of smoking in woman as 
will be discussed later. 
In our study no change in the mean age of the patients was observed. 
The number of patients below 40 years of age remained stable. This is 
in accordance with the study by Muller et al. who observed a more than 
fourfold increase of patients below 40 years of age in the period between 
1974 and the late 1980´s and then remaining stable thereafter until 
2006 (9). In a few studies, amongst others from Scotland and Ireland, an 
increasing incidence of oral cancer in young patients has been reported 
(12,13). No convincing explanation could be provided for that finding (14).
No differences between our two groups of patients were seen with regard 
to site distribution. The most common sites are the lateral borders of the 
tongue and the floor of mouth. This is in accordance with the literature 
(15-18).
In this study a clear difference between the two groups concerning T1- and 
N0-stages was seen. Remarkably, there were more patients diagnosed 
with T1 tumors in the 2000-2004 period. This suggests that patients with 
oral cancer are diagnosed in an earlier stage. Perhaps, this is caused by 
improved education of the public or increased awareness among dental 
and medical practitioners. In a study from an other head and neck cancer 
center in the Netherlands an increase in the percentage of patients with 
T4 oral cancers was observed, being 22,7% in the 1985-1989 period 
and 32,9% in the 1995-1998 period (19), while in the present study this 
percentage has only slightly increased in the two studied periods (10,0% 
and 12,5% respectively, being statistically not significantly different).
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In the study by Hoffman et al. the distribution of stages remained stable 
when comparing the years 1985-1989 and 1990-1994 in the US (20). 
However, in that study no distinction was made between cancer of the oral 
cavity and other head and neck cancers. 
Interestingly, in the present study in 2000-2004 more patients were 
classified with N0 stage of the neck. In the early 90´s the ultrasound 
guided fine needle aspiration was introduced for the staging process of 
the neck, which would result in a lower number of N0 cases. Most likely 
the increase of N0 patients in our group 2 (2000-2004) is related to the 
increased number of patients presenting with a lower T-stage at admission. 
In the Netherlands there is a clear decrease of the number of smokers 
after 1980. In 1980 43% of the population was smoking; in 2004 that 
number was 28%. However, we have not noticed this decrease in our 
patient groups. In male as well as female patients no differences in 
smoking habits between the two groups were observed. In our study no 
statistically significant difference in smoking habits in women between the 
two periods was observed.  
In the present study a significant decrease in the number of heavy drinkers 
between the two groups was observed; the percentages dropped from 
32% in the 1980-1984 period to 18% in the 2000-2004 period. In spite 
of less alcohol consumption and, in men, decreased smoking habits, one 
would expect to observe a decrease in the incidence of oral cancer, which 
is apparently not the case. No proper explanation can be provided for this 
observation (2,3).
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Summary and conclusions 
The present study is mainly focussed on the clinical relevance of a number 
of histopathological aspects of small (T1,T2) squamous cell carcinomas of 
the tongue and floor of mouth. In addition, some epidemiological aspects 
have been studied. After the introductory chapter 1, some aspects of 
the etiology, diagnosis, histopathology and staging of oral squamous cell 
carcinomas have been discussed in chapter 2. In Chapter 3, the clinical 
relevance of the presence of epithelial dysplasia in the surgical mucosal 
margins of tongue and floor of mouth squamous cell carcinomas with 
regard to local recurrence has been reported. A total number of 37 patients 
who have been surgically treated for a primary squamous cell carcinoma 
of the tongue and the floor of the mouth have been included. The follow-
up was five years. Local recurrence occurred in two out of 30 patients in 
whom no epithelial dysplasia was present, while 5 out of 7 patients with 
epithelial dysplasia developed a local recurrence, the difference between 
these two groups being statistically significant (Fisher exact test; p< 
0.01). Indeed, presence of epithelial dysplasia in the surgical mucosal 
margin has predictive value with regard to the development of local 
recurrence. Therefore, we recommend that the presence of dysplasia 
in the mucosal margin is mentioned in the histopathological report and 
advise the clinician in case of dysplasia (mild as well as moderate and 
severe) within the margins to immediately perform a  reexcision of the 
tumor site because of the high risk of local recurrence.
Unfortunately, the study on the role of DNA-ploidy measurement of  J. 
Sudbö (reference 12 chapter 3) has been withdrawn.
In chapter 4, the clinical relevance of tumor free deep surgical margins 
in oral carcinoma was studied retrospectively. A total of 68 patients was 
included.  All patients underwent surgical treatment of a squamous cell 
carcinoma of the tongue or floor of mouth. The follow-up was five years. 
Local recurrence occurred in two out of 30 patients with a tumor free deep 
surgical margin (no tumor within 0.5cm) and in 3 out of 38 patients with 
a close (tumor less than 0.5 cm) deep surgical margin This difference was 
not statistically significant. Therefore, no additional treatment in case of 
a close deep surgical margin ( <0.5) seems to be required.  However, 
margin status has proved  to be of  prognostic value in overall survival. A 
recent study of Nason et al, (1) showed a statistically significant decreased 
5-year survival rate in patients with positive margins as well as close 
(<3mm) margins. These findings are in concordance with Binahmed et al, 
(2) who found that involved surgival margins increased the risk of death 
at 5 years by 90%. In summary, we recommend additional treatment in 
case of involved or close (<3mm) deep surgical margins to improve the 
survival rate of the patient.
In chapter 5 the results of a retrospective study  on the possible value 
of the so-called histopathological malignancy grading system have been 
reported. For this purpose, the classical Broders’ grading system and the 
malignancy grading system have been compared with regard to various 
outcome measures such as regional metastasis, local recurrence and 
5-year survival in a number of 128 previously untreated patients with 
a T1 or T2 squamous cell carcinoma of the tongue and the floor of the 
mouth.  The results show that neither histopathological grading system 
has a strong predictive value and that none is superior to the other. Our 
advise to pathologists, however, is to use the malignancy grading system 
(MGS) of Anneroth and Bryne and to score the different items at the 
tumor front (invasive front grading). This because of the accuracy of the 
system and the clear scoring of the different items. What we did find 
in the study in chapter 5 was a tendency (not statistically significant) 
that perineural spread was associated with poor survival and that 
tumor growth in vessels was associated with increased risk of regional 
metastasis. Perineural spread is widely accepted as a prognostic factor 
of tumor aggressiveness. However, the specific mechanisms are not clear 
yet and further investigations are needed to develop therapeutic agents 
(3). Perineural spread and tumor growth in vessels are, indeed,  important 
items to be mentioned in the pathologist’s report and, when present, 
additional treatment should be considered. 
In the past decades numerous molecular and immunohistochemical 
markers have been examined for their possible predictive value of tumor 
behaviour of oral squamous cell carcinoma. No final conclusions can be 
drawn yet, with the possible exception of HPV type 16 positive tumors, 
particularly in cancer of the oropharynx, that seem to have a better 
prognosis and also show a better response to radiotherapy. 
In chapter 6, the mortality rate of 19 patients with a proven oral squamous 
cell carcinoma derived from a pre-existing oral leukoplakia was compared 
with that of a similar size group of patients with oral carcinoma without 
a pre-existing oral leukoplakia, being matched for gender, age, smoking 
habits, use of alcohol, oral subsite and histopathologic grade. Treatment 
in all patients consisted primarily of surgical excision. No significant 
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difference between the mortality rates up to five years of follow-up was 
observed between the two groups of patients. Apparently, patients with 
oral cancer developing from pre-existing oral leukoplakia do not do better 
than those with de novo oral cancer as sometimes has been suggested 
in the literature. Untill now, no treatment regimen has proven to truly 
prevent malignant transformation of oral leukoplakia (4).  Nevertheless, 
the general advice is to treat oral leukoplakia, if feasible, and to have the 
patient followed at intervals of no more than 4-6 months, lifelong. 
In chapter 7, the possible epidemiologic changes of oral cancer patients 
in the Netherlands between the years 1980-1984 and 2000-2004 are 
evaluated.  The male-female ratio, age, TNM-stage, site distribution, and 
alcohol and tobacco use were studied. Patients from the VU University 
Medical Center (formerly known as Free University Medical Centre) with 
squamous cell carcinoma of the oral cavity registered in 1980-1984 
(n=200; group 1),were compared to patients registered in 2000-2004 
(n=184; group 2). Trends in prevalence, site distribution, TNM-stage, 
alcohol and tobacco use, age and gender were studied. The male/female 
ratio in group 2 has decreased from 1.8 to 1.2. There were no differences 
in age between the two groups of patients. The site distribution was 
similar in both groups. The most commonly involved sites in both groups 
were the tongue and the floor of mouth. In  group 2 more patients were 
diagnosed with a T1 tumor. There were no differences in tobacco use 
between the two different groups. There were much more light drinkers 
(0-2 drinks per day) in group 2 than in group 1, whereas there were more 
heavy drinkers (>4 per day) in group 1 than in group 2 (p=<0.001). This 
was observed in both male and female patients. 
This study certainly leaves room for discussion. There are several 
methodological flaws. The studied patients were only patients treated 
at the Free University Medical Center in Amsterdam and this group of 
patients might not be representative in various aspects- such as ethnic 
background, age and gender- for the total population of Amsterdam or 
even The Netherlands. Even in a small country as The Netherlands, the 
demographic profile varies per geographic region. Furthermore, there 
might have been differences in the referral pattern in the two studied 
periods in Amsterdam where another head-and-neck cancer center is 
located. On the other hand, it is unlikely that such event may explain the 
observed differences with regard to the various parameters that have 
been studied. Nevertheless, the results of the present study should be 
looked at with some reservation.
We can conclude that, inspite of ongoing developments in different fields of 
diagnosis and treatment, i.e. imaging, surgical techniques, radiotherapy, 
and chemotherapy, the overall survival rate of patients with oral cancer 
has not improved over the last decades. Even in early (T1,T2) carcinomas 
there is a serious number of patients who develop locoregional metastasis, 
suffer from recurrent disease or die of their disease.  For prevention, 
creating awareness among patients as well as among primary health 
care workers, i.e. dentists and general medical practitioners, is of great 
importance. Especially creating awareness of the main risk factors like 
alcohol consumption and smoking can be of great importance. Primary 
health care workers can play a great role, indeed, in the cessation of 
tobacco and alcohol habits.    
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Samenvatting en conclusies
Deze studie is hoofdzakelijk gericht op de klinische relevantie van een aantal 
histopathologische aspecten van kleine (T1,T2) plaveiselcelcarcinomen 
van de tong en mondbodem. Tevens werden enkele epidemiologische 
aspecten bestudeerd. Na het introductie hoofdstuk 1, zijn enige 
aspecten van de etiologie, diagnose, histopathologie en stagering van 
het plaveiselcelcarcinoom van de mondholte belicht in hoofdstuk 2. 
In hoofdstuk 3 is de klinische relevantie van de aanwezigheid van 
epitheeldysplasie in de chirurgische slijmvliesresectieranden van tong- en 
mondbodem plaveiselcelcarcinomen in relatie tot het eventueel optreden 
van lokaal recidief besproken. In het totaal zijn 37 patiënten geïncludeerd 
die chirurgisch behandeld zijn voor een primair plaveiselcelcarcinoom 
van de tong of de mondbodem. De follow-up tijd was 5 jaar. Lokaal 
recidief trad op in 2 van de 30 patiënten bij wie geen dysplasie in de 
resectieranden gezien was, terwijl dit bij 5 van de 7 patiënten optrad 
met epitheeldysplasie in de resectieranden. Het verschil tussen deze twee 
groepen was statistisch significant (Fisher exact test: p<0.01). Hiermee 
is aangetoond dat epitheeldysplasie in de chirurgische slijmvliesranden 
voorspellende waarde heeft voor het ontstaan van een lokaal recidief. 
Daarom adviseren wij om de aanwezigheid van dysplasie in de chirurgische 
slijmvliesranden te vermelden in het histopathologie verslag en tevens 
adviseren wij de chirurg om in het geval van dysplasie (zowel mild, matig 
als ernstig) direct een reëxcisie uit te voeren vanwege het grote risico op 
een lokaal recidief. 
In hoofdstuk 4 is retrospectief de klinische relevantie van tumorvrije 
diepe chirurgische resectieranden in mondholtecarcinomen bestudeerd. 
In totaal zijn 68 patiënten onderzocht. Alle patiënten hadden een 
chirurgische behandeling ondergaan voor een plaveiselcelcarcinoom van 
de tong of de mondbodem. De  follow-up tijd was 5 jaar. Lokaal recidief 
trad op in 2 van de 30 patiënten met een tumorvrije resectierand (geen 
tumor binnen 0.5cm van de resectierand) en in 3 van de 38 patiënten 
met een krappe tumorvrije resectierand (tumor minder dan 0.5cm van de 
resectierand). Dit verschil was statistisch niet significant. 
In geval van een krappe diepe chirurgische resectierand (<0.5cm) is 
aanvullende behandeling niet altijd noodzakelijk. Niettemin, de status 
van de resectieranden heeft bewezen prognostische waarde wat betreft 
de overleving van de patiënt. Een recente studie van Nason (1), liet een 
significant verlaagde 5-jaars overleving zien bij zowel patiënten met 
een positieve resectierand,  als bij patiënten met een krappe (<3mm) 
resectierand. Deze bevindingen komen overeen met de studie van 
Binhamed (2). Deze studie toonde aan dat positieve resectieranden het 
risico op overlijden binnen 5 jaar met 90% deed toenemen. Samenvattend 
adviseren wij aanvullende behandeling in het geval van positieve of 
krappe (<3mm) resectieranden om de overlevingskansen van de patiënt 
te verbeteren. 
In hoofdstuk 5 zijn de resultaten van een retrospectieve studie naar de 
mogelijke waarde van het maligniteits graderingssysteem gepresenteerd. 
De voorspellende waarden van het klassieke Broders graderingssysteem 
en het maligniteits graderingssysteem zijn beoordeeld op verschillende 
parameters, zoals regionale metastasen, lokaal recidief en 5 jaars- 
overleving. Hiervoor zijn 128 niet eerder behandelde patiënten met 
een T1- of T2 plaveiselcelcarcinoom van de tong of de mondholte 
onderzocht. De resultaten tonen aan dat geen van de histopathologische 
graderingssystemen een sterk voorspellende waarde heeft en dat het ene 
systeem niet superieur is aan het andere. Toch is ons advies aan pathologen 
om het maligniteits graderingssysteem (MGS) van Anneroth en Bryne te 
gebruiken en de verschillende items in het tumorfront te scoren (invasive 
front grading). Dit vanwege de accuratesse van het systeem en het 
duidelijke scoren van de verschillende onderdelen. In hoofdstuk 5 werd 
er wel een tendens (niet statistisch significant) gevonden dat perineurale 
groei geassocieerd is met een slechte overleving en dat tumor groei in 
vaten geassocieerd is met een verhoogd risico op regionale metastasen. 
Perineurale groei is algemeen geaccepteerd als een prognostische factor 
voor tumor agressiviteit. De specifieke mechanismen zijn nog niet geheel 
duidelijk en nader onderzoek is nodig om therapeutische middelen te 
ontwikkelen (3). Perineurale groei en tumor groei in vaten zijn inderdaad 
belangrijke items om te vermelden in het verslag van de patholoog en 
indien aanwezig zal aanvullende behandeling overwogen moeten worden. 
In de afgelopen decennia zijn vele moleculaire immunohistochemische 
markers onderzocht op hun eventuele voorspellende waarde van de 
agressiviteit van het orale plaveiselcelcarcinoom. Er kunnen nog geen 
eindconclusies getrokken, worden maar het lijkt erop dat tumoren die 
HPV type-16 positief zijn een betere prognose hebben en ook een betere 
reactie geven op radiotherapie. 
In hoofdstuk 6 is het sterftecijfer van 19 patiënten met een 
plaveiselcelcarcinoom ontstaan vanuit leukoplakie vergeleken met 
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dat van een eveneens uit 19 patiënten bestaande groep met een 
plaveiselcelcarcinoom niet ontstaan vanuit leukoplakie. De groepen zijn 
“gematched” voor geslacht, leeftijd, rookgewoonten, alcoholgebruik, 
locatie in de mond en histopathologische gradering. Alle patiënten zijn 
primair chirurgisch behandeld. De sterftecijfers tot 5 jaar na behandeling 
zijn berekend volgens de Kaplan-Meier methode. Er is geen significant 
verschil gevonden tussen de twee groepen patiënten wat betreft de 
sterftecijfers. Hieruit blijkt dat patiënten met een mondholtecarcinoom 
ontstaan vanuit leukoplakie geen betere overleving hebben dan patiënten 
met een mondholtecarcinoom dat niet ontstaan is vanuit leukoplakie. 
Tot nu toe heeft geen enkele behandeling echt bewezen dat het maligne 
transformatie van een leukoplakie kan voorkomen (4). Ondanks dat is het 
algemene advies om een leukoplakie van de mondholte, indien mogelijk, 
te behandelen en de patiënt levenslang te controleren met een interval 
van niet meer dan 4-6 maanden. 
In hoofdstuk 7 zijn de mogelijke epidemiologische veranderingen van 
patiënten met een mondholtecarcinoom in Nederland in de jaren 1980-
1984 en 2000-2004 onderzocht. Er werd gekeken naar de verschillen in 
man-vrouw verhouding, leeftijd, TNM-stadium, lokalisatie en alcohol- en 
tabakgebruik. Patiënten van het Vrije Universiteit Medisch Centrum met 
een plaveiselcelcarcinoom van de mondholte, geregistreerd in 1980-
1984 (n=200; groep 1), zijn vergeleken met patiënten geregistreerd in 
2000-2004 (n=184; groep 2). De man-vrouw verhouding in de tweede 
groep nam af van 1.8 tot 1.2. Er waren geen verschillen in leeftijd tussen 
de twee patiëntengroepen. De verdeling van de lokalisaties was gelijk 
in beide groepen. De meest voorkomende lokalisaties in beide groepen 
waren de tong en de mondbodem. In de tweede groep zijn meer patiënten 
gediagnosticeerd met een T1 tumor. Het is onbekend of deze ‘eerdere’ 
diagnose heeft geresulteerd in een betere overleving van de patiënten 
in deze groep. Er waren geen verschillen in tabakgebruik tussen de twee 
groepen. Wel werden er verschillen in alcoholgebruik waargenomen. Er 
waren meer lichte drinkers (0-2 consumpties per dag) in de tweede groep 
dan in de eerste, terwijl er meer zware drinkers (>4 per dag) in de eerste 
groep patiënten waren. Dit gold voor zowel mannen als vrouwen. 
Deze studie laat zeker ruimte voor discussie. Er zijn namelijk enige 
methodologische gebreken. De bestudeerde patiënten groep bestond 
alleen uit  patiënten die behandeld waren in het Vrije Universiteit Medisch 
Centrum in Amsterdam. Deze groep is wellicht niet representatief in 
verscheidene opzichten- zoals etnische achtergrond, leeftijd en geslacht- 
voor de totale Amsterdamse populatie of zelfs de Nederlandse populatie. 
Zelfs in een klein land als Nederland varieert het demografische profiel 
per provincie. Tevens is het mogelijk dat er verschillen zijn opgetreden 
in het patroon van verwijzen in Amsterdam, waar nog een ander hoofd-
hals kanker-centrum is gelokaliseerd, tussen de twee bestudeerde 
periodes. Aan de andere kant is het onwaarschijnlijk dat dit gegeven de 
gevonden verschillen tussen de verschillende parameters kan verklaren. 
Desalniettemin moeten de resultaten van deze studie met enige 
terughoudendheid worden bekeken. 
Concluderend kan worden gesteld, dat ondanks voortschrijdende 
ontwikkelingen op verschillende gebieden zoals beeldvorming, chirurgische 
en radiotherapeutische technieken en chemotherapie, de gemiddelde 
overlevingskans van patiënten met mondholtecarcinomen de laatste 
decennia niet duidelijk is verbeterd. Zelfs in een vroeg stadium (T1,T2) 
is er een groot aantal patiënten die lokale metastasen ontwikkelen, een 
lokaal recidief krijgen of overlijden aan hun ziekte. Voor preventie van 
mondholtecarcinomen is het bewust maken van niet alleen patiënten maar 
ook van eerstelijns gezondheidswerkers, zoals huisartsen, tandartsen 
en mondzorgkundigen, van groot belang. Vooral bewustwording van de 
voornaamste risicofactoren, zoals alcoholgebruik en roken, is essentieel. 
Tevens kunnen eerstelijns gezondheidswerkers een grote rol spelen in het 
stopen met roken of alcoholmisbruik. 
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Speel het spel
Breng je werk in gevaar,
Wees niet de hoofdpersoon.
Zoek de confrontatie maar doe het onopzettelijk.
Vermijd bijbedoelingen.
Verzwijg niet.
Wees week en sterk, wees slim.
Steek je nek uit en veracht de overwinning.
Kijk niet toe, bewijs niets,
maar blijf met alle tegenwoordigheid van geest open voor tekens.
Laat je ogen zien, laat anderen erin kijken.
Zorg voor ruimte en beschouw ieder in zijn eigen perspectief.
Beslis alleen met hartstocht.
Misluk rustig.
Neem vooral de tijd en bewandel zijpaden.
Laat je afleiden, neem om het zo te zeggen vakantie.
Houdt je niet doof, voor geen boom, voor geen water.
Trek je terug in jezelf als je daar zin in hebt en gun je de zon.
Vergeet de mensen in je naaste omgeving.
Verstevig de banden met onbekenden.
Buig je over bijzaken. Wijk uit naar de verlatenheid.
Vermoord het noodlotsdrama, veracht het ongeluk,
analyseer het conflict.
Neem je eigen kleur aan, tot je in je gelijk staat
en het ruisen van de bladeren zoet wordt.
Loop stilzwijgend langs de dorpen.
Ik volg je.
Over de dorpen - Peter Handke
 
 

